• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恩培多普汀(BMY - 28117),一种新型缩肽抗生素。I. 生产、分离及特性

Empedopeptin (BMY-28117), a new depsipeptide antibiotic. I. Production, isolation and properties.

作者信息

Konishi M, Sugawara K, Hanada M, Tomita K, Tomatsu K, Miyaki T, Kawaguchi H, Buck R E, More C, Rossomano V Z

出版信息

J Antibiot (Tokyo). 1984 Sep;37(9):949-57. doi: 10.7164/antibiotics.37.949.

DOI:10.7164/antibiotics.37.949
PMID:6501108
Abstract

Empedopeptin is a new antibiotic produced by empedobacter haloabium nov. sp. (ATCC 31962). It is a water-soluble depsipeptide antibiotic containing eight amino acid residues and a C14-fatty acid moiety in the molecule. Although structurally unrelated, empedopeptin and vancomycin have similar antimicrobial spectra against aerobic and anaerobic Gram-positive bacteria including antibiotic-resistant strains. Empedopeptin is highly active in vivo in mice against systemic infections of Staphylococcus aureus, Streptococcus pyogenes and Clostridium perfringens. Empedopeptin is not absorbed orally.

摘要

恩培多肽是由嗜盐栖居杆菌新种(ATCC 31962)产生的一种新型抗生素。它是一种水溶性缩肽抗生素,分子中含有八个氨基酸残基和一个C14脂肪酸部分。尽管恩培多肽和万古霉素在结构上不相关,但它们对需氧和厌氧革兰氏阳性菌(包括耐药菌株)具有相似的抗菌谱。恩培多肽在小鼠体内对金黄色葡萄球菌、化脓性链球菌和产气荚膜梭菌的全身感染具有高度活性。恩培多肽口服不吸收。

相似文献

1
Empedopeptin (BMY-28117), a new depsipeptide antibiotic. I. Production, isolation and properties.恩培多普汀(BMY - 28117),一种新型缩肽抗生素。I. 生产、分离及特性
J Antibiot (Tokyo). 1984 Sep;37(9):949-57. doi: 10.7164/antibiotics.37.949.
2
Empedopeptin (BMY-28117), a new depsipeptide antibiotic. II. Structure determination.恩肽霉素(BMY - 28117),一种新型缩酚酸肽类抗生素。II. 结构测定。
J Antibiot (Tokyo). 1984 Sep;37(9):958-64. doi: 10.7164/antibiotics.37.958.
3
Integrated Omics Strategy Reveals Cyclic Lipopeptides Empedopeptins from sp. YMA4 and Their Biosynthetic Pathway.综合组学策略揭示了 sp. YMA4 来源的环状脂肽 empedopeptins 及其生物合成途径。
Mar Drugs. 2021 Apr 9;19(4):209. doi: 10.3390/md19040209.
4
Glysperin, a new antibiotic complex of bacterial origin. I. Production, isolation and properties.格利菌素,一种新的源自细菌的抗生素复合物。I. 生产、分离及特性
J Antibiot (Tokyo). 1981 Apr;34(4):381-9. doi: 10.7164/antibiotics.34.381.
5
Bu-2313, a new antibiotic complex active against anaerobes. I. Production, isolation and properties of Bu-2313 A and B.布-2313,一种对厌氧菌有活性的新型抗生素复合物。I. 布-2313 A和B的产生、分离及特性
J Antibiot (Tokyo). 1980 Feb;33(2):157-65. doi: 10.7164/antibiotics.33.157.
6
Studies on bacterial cell wall inhibitors. VII. Azureomycins A and B, new antibiotics produced by Pseudonocardia azurea nov. sp. Taxonomy of the producing organism, isolation, characterization and biological properties.细菌细胞壁抑制剂的研究。VII. 天蓝霉素A和B,新的抗生素,由天蓝假诺卡氏菌新种产生。产生菌的分类学、分离、特性及生物学特性 。
J Antibiot (Tokyo). 1979 Oct;32(10):985-94. doi: 10.7164/antibiotics.32.985.
7
Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.替考霉素:与其他抗生素相比的体外和体内评价
J Antimicrob Chemother. 1983 May;11(5):419-25. doi: 10.1093/jac/11.5.419.
8
Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. Fermentation, isolation, structure, and antimicrobial activity.硫代马里诺醇,一种由海洋细菌产生的新型混合抗菌抗生素。发酵、分离、结构及抗菌活性。
J Antibiot (Tokyo). 1993 Dec;46(12):1834-42. doi: 10.7164/antibiotics.46.1834.
9
[A new metabolite with fungistatic and bacteriostatic activity, produced by strain L-30 of Flavobacterium sp].[一种由黄杆菌属L-30菌株产生的具有抑菌和抑真菌活性的新代谢产物]
Antibiot Khimioter. 1996 May;41(5):6-12.
10
Isolation and characterization of hypeptin from Pseudomonas sp.从假单胞菌属中分离和鉴定海肽素
J Antibiot (Tokyo). 1989 Oct;42(10):1460-4. doi: 10.7164/antibiotics.42.1460.

引用本文的文献

1
Integrated Omics Strategy Reveals Cyclic Lipopeptides Empedopeptins from sp. YMA4 and Their Biosynthetic Pathway.综合组学策略揭示了 sp. YMA4 来源的环状脂肽 empedopeptins 及其生物合成途径。
Mar Drugs. 2021 Apr 9;19(4):209. doi: 10.3390/md19040209.
2
Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.靶向细菌的致命弱点:细菌战中破坏肽聚糖细胞壁的不同机制。
J Bacteriol. 2021 Mar 8;203(7). doi: 10.1128/JB.00478-20.
3
The Draft Whole-Genome Sequence of the Antibiotic Producer Empedobacter haloabium ATCC 31962 Provides Indications for Its Taxonomic Reclassification.
抗生素产生菌嗜盐栖居杆菌ATCC 31962的全基因组序列草图为其分类重新界定提供了线索。
Microbiol Resour Announc. 2019 Nov 7;8(45):e01120-19. doi: 10.1128/MRA.01120-19.
4
Advances in MRSA drug discovery: where are we and where do we need to be?耐甲氧西林金黄色葡萄球菌药物研发进展:我们现在处于何处,又需要去往何方?
Expert Opin Drug Discov. 2013 Sep;8(9):1095-116. doi: 10.1517/17460441.2013.807246. Epub 2013 Jul 6.
5
Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.脂肽empedopeptin 通过与肽聚糖前体形成 Ca2+依赖性复合物来抑制细胞壁生物合成。
J Biol Chem. 2012 Jun 8;287(24):20270-80. doi: 10.1074/jbc.M112.369561. Epub 2012 Apr 18.
6
Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.三肽菌素 C 通过与十一异戊烯焦磷酸形成复合物来阻断细胞壁生物合成的脂质循环。
Antimicrob Agents Chemother. 2011 Aug;55(8):3821-8. doi: 10.1128/AAC.00443-11. Epub 2011 May 31.